Report Content
Chapter 1 Methodology
1.1 Market definition
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 U.S. medical marijuana industry 3600 synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Application trends
2.1.3 Route of administration trends
2.1.4 Distribution channel trends
2.1.5 Zonal trends
Chapter 3 US Medical Marijuana Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing application of marijuana for a myriad of medical conditions and symptoms
3.3.1.2 Growing demand for medical marijuana legalization in several countries
3.3.1.3 Rising number of R&D and clinical trial activities
3.3.2 Industry pitfalls & challenges
3.3.2.1 Few side effects might hinder the market growth
3.3.2.2 Difficulty in medical marijuana business banking
3.4 Growth potential analysis
3.4.1 By application
3.4.2 By route of administration
3.4.3 By distribution channel
3.5 COVID-19 impact analysis
3.6 Regulatory landscape & guidelines
3.6.1 Alaska
3.6.2 Arizona
3.6.3 Arkansas
3.6.4 California
3.6.5 Colorado
3.6.6 Connecticut
3.6.7 Delaware
3.6.8 Florida
3.6.9 Hawaii
3.6.10 Illinois
3.6.11 Louisiana
3.6.12 Maine
3.6.13 Maryland
3.6.14 Massachusetts
3.6.15 Michigan
3.6.16 Minnesota
3.6.17 Montana
3.6.18 Missouri
3.6.19 Nevada
3.6.20 New Hampshire
3.6.21 New Jersey
3.6.22 New Mexico
3.6.23 New York
3.6.24 North Dakota
3.6.25 Pennsylvania
3.6.26 Ohio
3.6.27 Oklahoma
3.6.28 Oregon
3.6.29 Rhode Island
3.6.30 South Dakota
3.6.31 Utah
3.6.32 Virginia
3.6.33 Vermont
3.6.34 West Virginia
3.6.35 Washington
3.6.36 Washington D.C.
3.7 Value chain analysis
3.8 Legal requirement for distribution of medical marijuana
3.9 Porter’s analysis
3.10 Competitive landscape, 2021
3.10.1 Company matrix analysis, 2021
3.11 PESTEL analysis
Chapter 4 US Medical Marijuana Market, By Application
4.1 Key segment trends
4.2 Pain Management
4.2.1 Market size, by zones, 2017 - 2030 (USD Million)
4.2.2 Neuropathic pain
4.2.2.1 Market size, by zones, 2017 - 2030 (USD Million)
4.2.3 Cancer pain
4.2.3.1 Market size, by zones, 2017 - 2030 (USD Million)
4.2.4 Others
4.2.4.1 Market size, by zones, 2017 - 2030 (USD Million)
4.3 Muscle spasms
4.3.1 Market size, by zones, 2017 - 2030 (USD Million)
4.4 Nausea
4.4.1 Market size, by zones, 2017 - 2030 (USD Million)
4.5 Anorexia
4.5.1 Market size, by zones, 2017 - 2030 (USD Million)
4.6 Seizures
4.6.1 Market size, by zones, 2017 - 2030 (USD Million)
4.7 Others
4.7.1 Market size, by zones, 2017 - 2030 (USD Million)
Chapter 5 US Medical Marijuana Market, By Route of Administration
5.1 Key segment trends
5.2 Inhalation
5.2.1 Market size, by zones, 2017 - 2030 (USD Million)
5.3 Oral
5.3.1 Market size, by zones, 2017 - 2030 (USD Million)
5.4 Topical
5.4.1 Market size, by zones, 2017 - 2030 (USD Million)
Chapter 6 US Medical Marijuana Market, By Distribution Channel
6.1 Key segment trends
6.2 Dispensaries
6.2.1 Market size, by zones, 2017 - 2030 (USD Million)
6.3 Online
6.3.1 Market size, by zones, 2017 - 2030 (USD Million)
Chapter 7 US Medical Marijuana Market, By Zone
7.1 Key zonal trends
7.2 North East
7.2.1 Market size, by states, 2017 - 2030 (USD Million)
7.2.2 Market size, by application, 2017 - 2030 (USD Million)
7.2.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.2.3 Market size, by route of administration, 2017 - 2030 (USD Million)
7.2.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.2.5 Connecticut
7.2.5.1 Market size, by application, 2017 - 2030 (USD Million)
7.2.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.2.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.2.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.2.6 Maine
7.2.6.1 Market size, by application, 2017 - 2030 (USD Million)
7.2.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.2.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.2.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.2.7 Massachusetts
7.2.7.1 Market size, by application, 2017 - 2030 (USD Million)
7.2.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.2.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.2.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.2.8 New Hampshire
7.2.8.1 Market size, by application, 2017 - 2030 (USD Million)
7.2.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.2.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.2.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.2.9 Rhode Island
7.2.9.1 Market size, by application, 2017 - 2030 (USD Million)
7.2.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.2.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.2.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.2.10 Vermont
7.2.10.1 Market size, by application, 2017 - 2030 (USD Million)
7.2.10.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.2.10.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.2.10.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.2.11 New Jersey
7.2.11.1 Market size, by application, 2017 - 2030 (USD Million)
7.2.11.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.2.11.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.2.11.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.2.12 New York
7.2.12.1 Market size, by application, 2017 - 2030 (USD Million)
7.2.12.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.2.12.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.2.12.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.2.13 Pennsylvania
7.2.13.1 Market size, by application, 2017 - 2030 (USD Million)
7.2.13.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.2.13.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.2.13.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.3 East North Central
7.3.1 Market size, by states, 2017 - 2030 (USD Million)
7.3.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.3.3 Market size, by route of administration, 2017 - 2030 (USD Million)
7.3.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.3.5 Illinois
7.3.5.1 Market size, by application, 2017 - 2030 (USD Million)
7.3.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.3.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.3.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.3.6 Michigan
7.3.6.1 Market size, by application, 2017 - 2030 (USD Million)
7.3.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.3.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.3.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.3.7 Ohio
7.3.7.1 Market size, by application, 2017 - 2030 (USD Million)
7.3.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.3.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.3.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.4 South Atlantic
7.4.1 Market size, by states, 2017 - 2030 (USD Million)
7.4.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.4.3 Market size, by route of administration, 2017 - 2030 (USD Million)
7.4.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.4.5 Delaware
7.4.5.1 Market size, by application, 2017 - 2030 (USD Million)
7.4.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.4.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.4.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.4.6 Florida
7.4.6.1 Market size, by application, 2017 - 2030 (USD Million)
7.4.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.4.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.4.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.4.7 Maryland
7.4.7.1 Market size, by application, 2017 - 2030 (USD Million)
7.4.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.4.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.4.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.4.8 Washington D.C.
7.4.8.1 Market size, by application, 2017 - 2030 (USD Million)
7.4.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.4.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.4.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.4.9 Virginia
7.4.9.1 Market size, by application, 2017 - 2030 (USD Million)
7.4.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.4.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.4.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.4.10 West Virginia
7.4.10.1 Market size, by application, 2017 - 2030 (USD Million)
7.4.10.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.4.10.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.4.10.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.5 West North Central
7.5.1 Market size, by states, 2017 - 2030 (USD Million)
7.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.5.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.5.3 Market size, by route of administration, 2017 - 2030 (USD Million)
7.5.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.5.5 Minnesota
7.5.5.1 Market size, by application, 2017 - 2030 (USD Million)
7.5.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.5.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.5.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.5.6 Missouri
7.5.6.1 Market size, by application, 2017 - 2030 (USD Million)
7.5.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.5.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.5.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.5.7 North Dakota
7.5.7.1 Market size, by application, 2017 - 2030 (USD Million)
7.5.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.5.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.5.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.5.8 South Dakota
7.5.8.1 Market size, by application, 2017 - 2030 (USD Million)
7.5.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.5.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.5.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.6 Pacific Central
7.6.1 Market size, by states, 2017 - 2030 (USD Million)
7.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.6.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.6.3 Market size, by route of administration, 2017 - 2030 (USD Million)
7.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.6.5 California
7.6.5.1 Market size, by application, 2017 - 2030 (USD Million)
7.6.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.6.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.6.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.6.6 Alaska
7.6.6.1 Market size, by application, 2017 - 2030 (USD Million)
7.6.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.6.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.6.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.6.7 Hawaii
7.6.7.1 Market size, by application, 2017 - 2030 (USD Million)
7.6.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.6.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.6.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.6.8 Oregon
7.6.8.1 Market size, by application, 2017 - 2030 (USD Million)
7.6.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.6.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.6.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.6.9 Washington
7.6.9.1 Market size, by application, 2017 - 2030 (USD Million)
7.6.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.6.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.6.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.7 Mountain States
7.7.1 Market size, by states, 2017 - 2030 (USD Million)
7.7.2 Market size, by application, 2017 - 2030 (USD Million)
7.7.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.7.3 Market size, by route of administration, 2017 - 2030 (USD Million)
7.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.7.5 Arizona
7.7.5.1 Market size, by application, 2017 - 2030 (USD Million)
7.7.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.7.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.7.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.7.6 Colorado
7.7.6.1 Market size, by application, 2017 - 2030 (USD Million)
7.7.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.7.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.7.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.7.7 Nevada
7.7.7.1 Market size, by application, 2017 - 2030 (USD Million)
7.7.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.7.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.7.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.7.8 New Mexico
7.7.8.1 Market size, by application, 2017 - 2030 (USD Million)
7.7.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.7.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.7.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.7.9 Montana
7.7.9.1 Market size, by application, 2017 - 2030 (USD Million)
7.7.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.7.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.7.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.7.10 Utah
7.7.10.1 Market size, by application, 2017 - 2030 (USD Million)
7.7.10.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.7.10.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.7.10.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.8 West South Central
7.8.1 Market size, by states, 2017 - 2030 (USD Million)
7.8.2 Market size, by application, 2017 - 2030 (USD Million)
7.8.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.8.3 Market size, by route of administration, 2017 - 2030 (USD Million)
7.8.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.8.5 Arkansas
7.8.5.1 Market size, by application, 2017 - 2030 (USD Million)
7.8.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.8.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.8.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.8.6 Oklahoma
7.8.6.1 Market size, by application, 2017 - 2030 (USD Million)
7.8.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.8.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.8.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
7.8.7 Louisiana
7.8.7.1 Market size, by application, 2017 - 2030 (USD Million)
7.8.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
7.8.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
7.8.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard
8.2 Canopy Growth Corporation
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Service landscape
8.2.4 SWOT analysis
8.3 Aurora Cannabis, Inc.
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Service landscape
8.3.4 SWOT analysis
8.4 GW Pharmaceuticals
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Service landscape
8.4.4 SWOT analysis
8.5 Medical Marijuana, Inc.
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Service landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Cannabis Sativa, Inc.
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Service landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 Emerald Health Therapeutics Inc.
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Service landscape
8.7.4 SWOT analysis
8.8 The Cronos Group Inc.
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Service landscape
8.8.4 SWOT analysis
8.9 Tilray
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Service landscape
8.9.4 SWOT analysis
8.10 Lexaria Bioscience Corp
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Service landscape
8.10.4 SWOT analysis
8.11 Curaleaf
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Service landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
8.12 Green Roads
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Service landscape
8.12.4 Strategic outlook
8.12.5 SWOT analysis
8.13 CHARLOTTE’S WEB
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Service landscape
8.13.4 Strategic outlook
8.13.5 SWOT analysis
8.14 Gaia Herbs
8.14.1 Business overview
8.14.2 Financial data
8.14.3 Service landscape
8.14.4 Strategic outlook
8.14.5 SWOT analysis
8.15 Folium Biosciences
8.15.1 Business overview
8.15.2 Financial data
8.15.3 Service landscape
8.15.4 Strategic outlook
8.15.5 SWOT analysis
